ZFP42 acts as an oncogene in prostate cancer, cervical cancer and glioblastoma multiforme [24, 25, 41], whereas ZFP42 is identified as a tumor suppressor gene in hepatocellular carcinoma and renal cell carcinoma [26, 42]. The gene discussed is ZFP42; the disease is prostate carcinoma.